ExodusPoint Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-721
| Closed | -$514K | – | 1793 |
|
|
2024
Q4 | $514K | Sell |
721
-7,047
| -91% | -$5.02M | ﹤0.01% | 1047 |
|
|
2024
Q3 | $8.17M | Buy |
7,768
+4,282
| +123% | +$4.5M | 0.05% | 240 |
|
|
2024
Q2 | $3.66M | Sell |
3,486
-9,785
| -74% | -$10.3M | 0.03% | 469 |
|
|
2024
Q1 | $12.8M | Buy |
+13,271
| New | +$12.8M | 0.1% | 141 |
|
|
2023
Q3 | – | Sell |
-2,858
| Closed | -$2.05M | – | 1976 |
|
|
2023
Q2 | $2.05M | Sell |
2,858
-28,975
| -91% | -$20.8M | 0.02% | 712 |
|
|
2023
Q1 | $26.2M | Buy |
31,833
+12,777
| +67% | +$10.5M | 0.22% | 58 |
|
|
2022
Q4 | $13.7M | Buy |
+19,056
| New | +$13.7M | 0.2% | 110 |
|
|
2022
Q3 | – | Sell |
-6,390
| Closed | -$3.78M | – | 2176 |
|
|
2022
Q2 | $3.78M | Buy |
+6,390
| New | +$3.78M | 0.05% | 475 |
|
|
2022
Q1 | – | Sell |
-1,918
| Closed | -$1.21M | – | 2528 |
|
|
2021
Q4 | $1.21M | Buy |
1,918
+786
| +69% | +$496K | 0.01% | 933 |
|
|
2021
Q3 | $685K | Sell |
1,132
-566
| -33% | -$343K | 0.01% | 1181 |
|
|
2021
Q2 | $948K | Sell |
1,698
-15,064
| -90% | -$8.41M | 0.01% | 976 |
|
|
2021
Q1 | $7.93M | Buy |
16,762
+9,032
| +117% | +$4.27M | 0.12% | 151 |
|
|
2020
Q4 | $3.73M | Buy |
7,730
+4,840
| +167% | +$2.34M | 0.04% | 304 |
|
|
2020
Q3 | $1.62M | Buy |
+2,890
| New | +$1.62M | 0.03% | 431 |
|
|
2020
Q2 | – | Sell |
-2,469
| Closed | -$1.21M | – | 1945 |
|
|
2020
Q1 | $1.21M | Buy |
+2,469
| New | +$1.21M | 0.07% | 230 |
|
|
2019
Q1 | – | Sell |
-4,803
| Closed | -$1.79M | – | 741 |
|
|
2018
Q4 | $1.79M | Buy |
+4,803
| New | +$1.79M | 0.13% | 56 |
|